Intermetatarsal Neuroma Clinical Trial
Official title:
A 3-arm Randomized Controlled Study Comparing Ultrasound-guided Cryoablation, Ultrasound-guided Perineural Lidocaine and Ultrasound-guided Perineural Saline to Treat Intermetatarsal Neuroma
The purpose of this study is to evaluate the effectiveness of a device that delivers freezing temperature compared to injecting lidocaine (an anesthetic medication) in providing pain relief to patients with disorganized nerve bundle between the toes, also known as Morton's neuroma. The same ultrasound technology that the obstetricians use to visualize a fetus inside a pregnant woman will be used to help the study physician to locate the Morton's neuroma while precisely delivering the freezing temperature and lidocaine near the nerve.
This study will be a 3-arm randomized single-blinded placebo controlled study in which human
subjects with intermetatarsal neuralgia will receive subcutaneous normal saline or
subcutaneous lidocaine or ultrasound guided cryoablation. The first follow up will take place
4 weeks post procedure to monitor the magnitude and duration of pain relief. Subjects will
then be crossed over. Those who had received saline or lidocaine will receive ultrasound
guided cryoablation. Individuals, who had previously been given ultrasound guided
cryoablation without any improvement, may opt for another denervation procedure at 4 weeks.
All of the participants will be followed up at 3 months post procedure to determine the
magnitude and duration of pain relief.
Study procedures will be conducted by the principle investigator who is a Board Certified
pain management attending physician and an expert in performing ultrasonography guided
interventions The cryoablation device is routinely used to treat various painful pathologies
at Mount Sinai and Beth Israel pain management offices. The device manual and instructions
will be available at both locations. All research staff has prior experience working with
individuals with foot and ankle injuries at Mount Sinai.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05685160 -
US and MRI of the Forefoot: Intermetatarsal Bursitis or Morton's Neuroma
|
N/A |